AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families
Authors: Vasen, HFA Stormorken, A Menko, FH Nagengast, FM Kleibeuker, JH Griffioen, G Taal, BG Moller, P Wijnen, JT
Citation: Hfa. Vasen et al., MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families, J CL ONCOL, 19(20), 2001, pp. 4074-4080
The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer
Authors: Watson, P Butzow, R Lynch, HT Mecklin, JP Jarvinen, HJ Vasen, HFA Madlensky, L Fidalgo, P Bernstein, I
Citation: P. Watson et al., The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer, GYNECOL ONC, 82(2), 2001, pp. 223-228
Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutchpedigree
Authors: Wagner, A Hendriks, Y Meijers-Heijboer, EJ de Leeuw, WJF Morreau, H Hofstra, R Tops, C Bik, E Brocker-Vriends, AHJT van der Meer, C Lindhout, D Vasen, HFA Breuning, MH Cornelisse, CJ van Krimpen, C Niermeijer, MF Zwinderman, AH Wijnen, J Fodde, R
Citation: A. Wagner et al., Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutchpedigree, J MED GENET, 38(5), 2001, pp. 318-322
Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients
Authors: Vasen, HFA van Duijvendijk, P Buskens, E Bulow, C Bjork, J Jarvinen, HJ Bulow, S
Citation: Hfa. Vasen et al., Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients, GUT, 49(2), 2001, pp. 231-235
Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?
Authors: Vasen, HFA Morreau, H Nortier, JWR
Citation: Hfa. Vasen et al., Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?, AM J HU GEN, 68(6), 2001, pp. 1533-1534
Clinical diagnosis and management of hereditary colorectal cancer syndromes
Authors: Vasen, HFA
Citation: Hfa. Vasen, Clinical diagnosis and management of hereditary colorectal cancer syndromes, J CL ONCOL, 18(21), 2000, pp. 81S-92S
Colorectal cancer and family history
Authors: Vasen, HFA
Citation: Hfa. Vasen, Colorectal cancer and family history, ANN CHIR GY, 89(3), 2000, pp. 179-184
Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients
Authors: de Leeuw, WJF Dierssen, J Vasen, HFA Wijnen, JT Kenter, GG Meijers-Heijboer, H Brocker-Vriends, A Stormorken, A Moller, P Menko, F Cornelisse, CJ Morreau, H
Citation: Wjf. De Leeuw et al., Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients, J PATHOLOGY, 192(3), 2000, pp. 328-335
Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis
Authors: Peelen, T de Leeuw, W van Lent, K Morreau, H van Eijk, R van Vliet, M Wijnen, J Ligtenberg, M Ginjaar, HB Zweemer, R Menko, F Fodde, R van Ommen, GJB Vasen, HFA Cornelisse, CJ Devilee, P
Citation: T. Peelen et al., Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis, INT J CANC, 88(5), 2000, pp. 778-782
Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden)
Authors: Vasen, HFA Gruis, NA Frants, RR van der Velden, PA Hille, ETM Bergman, W
Citation: Hfa. Vasen et al., Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden), INT J CANC, 87(6), 2000, pp. 809-811
When should endoscopic screening in familial adenomatous polyposis be started?
Authors: Vasen, HFA
Citation: Hfa. Vasen, When should endoscopic screening in familial adenomatous polyposis be started?, GASTROENTY, 118(4), 2000, pp. 808-809
Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis
Authors: van Duijvendijk, P Slors, JFM Taat, CW Oosterveld, P Sprangers, MAG Obertop, H Vasen, HFA
Citation: P. Van Duijvendijk et al., Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis, BR J SURG, 87(5), 2000, pp. 590-596
Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families
Authors: Peelen, T van Vliet, M Bosch, A Bignell, G Vasen, HFA Klijn, JGM Meijers-Heijboer, H Stratton, M van Ommen, GJB Cornelisse, CJ Devilee, P
Citation: T. Peelen et al., Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families, BR J CANC, 82(1), 2000, pp. 151-156
Cumulative risk of developing polyps or malignancy at the ileal pouch-analanastomosis in patients with familial adenomatous polyposis
Authors: van Duijvendijk, P Vasen, HFA Bertario, L Bulow, S Kuijpers, JHC Schouten, WR Guillem, JG Taat, CW Slors, JFM
Citation: P. Van Duijvendijk et al., Cumulative risk of developing polyps or malignancy at the ileal pouch-analanastomosis in patients with familial adenomatous polyposis, J GASTRO S, 3(3), 1999, pp. 325-329
Treatment of mesenteric desmoid tumours with the antioestrogenic agent toremifene: case histories and an overview of the literature
Authors: Bus, PJ Verspaget, HW van Krieken, JHJM de Roos, A Keizer, HJ Bemelman, WA Vasen, HFA Lamers, CBHW Griffioen, G
Citation: Pj. Bus et al., Treatment of mesenteric desmoid tumours with the antioestrogenic agent toremifene: case histories and an overview of the literature, EUR J GASTR, 11(10), 1999, pp. 1179-1183
Familial adenomatous polyposis: from bedside to bench and vice versa - A tribute to the somatic cell geneticist P. Meera Khan
Authors: Griffioen, G Vasen, HFA Verspaget, HW Lamers, CBHW
Citation: G. Griffioen et al., Familial adenomatous polyposis: from bedside to bench and vice versa - A tribute to the somatic cell geneticist P. Meera Khan, CYTOG C GEN, 86(2), 1999, pp. 125-129
Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer
Authors: Vasen, HFA Wijnen, J
Citation: Hfa. Vasen et J. Wijnen, Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer, CYTOG C GEN, 86(2), 1999, pp. 136-139
Current policies for surveillance and management in women at risk for breast and ovarian cancer: A survey among 16 European family cancer clinics
Authors: Vasen, HFA Haites, NE Evans, DGR Steel, CM Moller, P Hodgson, S Eccles, D Morrison, P Stoppa-Lyonnet, D Chang-Claude, J Caligo, M
Citation: Hfa. Vasen et al., Current policies for surveillance and management in women at risk for breast and ovarian cancer: A survey among 16 European family cancer clinics, DIS MARKER, 15(1-3), 1999, pp. 47-47
Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
Authors: Stoppa-Lyonnet, D Caligo, M Eccles, D Evans, DGR Haites, NE Hodgson, NS Moller, P Morrison, PJ Steel, CM Vasen, HFA Chang-Claude, J
Citation: D. Stoppa-lyonnet et al., Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?, DIS MARKER, 15(1-3), 1999, pp. 67-68
Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe
Authors: Morrison, PJ Steel, CM Vasen, HFA Eccles, D Evans, DGR Moller, P Hodgson, S Stoppa-Lyonnet, D Chang-Claude, J Caligo, M Olah, E Haites, NE Nevin, NC
Citation: Pj. Morrison et al., Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe, DIS MARKER, 15(1-3), 1999, pp. 159-165
P. Meera Khan (1935-1998)
Authors: Vasen, HFA
Citation: Hfa. Vasen, P. Meera Khan (1935-1998), J GENETICS, 78(1), 1999, pp. 63-70
Gene-environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing
Authors: Park, JG Park, YJ Wijnen, JT Vasen, HFA
Citation: Jg. Park et al., Gene-environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing, INT J CANC, 82(4), 1999, pp. 516-519
Suspected hereditary nonpolyposis colorectal cancer - International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis
Authors: Park, JG Vasen, HFA Park, KJ Peltomaki, P de Leon, MP Rodriguez-Bigas, MA Lubinski, J Beck, NE Bisgaard, ML Miyaki, M Wijnen, JT Baba, S Lynch, HT
Citation: Jg. Park et al., Suspected hereditary nonpolyposis colorectal cancer - International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis, DIS COL REC, 42(6), 1999, pp. 710-715
Functional outcome after colectomy and ileorectal anastomosis compared with proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis
Authors: van Duijvendijk, P Slors, JFM Taat, CW Oosterveld, P Vasen, HFA
Citation: P. Van Duijvendijk et al., Functional outcome after colectomy and ileorectal anastomosis compared with proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis, ANN SURG, 230(5), 1999, pp. 648-654
Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics
Authors: Vasen, HFA Haites, NE Evans, DGR Steel, CM Moller, P Hodgson, S Eccles, D Morrison, P Lyonet, DS Chang-Claude, J Caligo, M
Citation: Hfa. Vasen et al., Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics, EUR J CANC, 34(12), 1998, pp. 1922-1926
Risultati: 1-25 | 26-26